Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
[ad_1] The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such…
2024-07-08 16:17:11
[ad_1] The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such…
[ad_1] Worries over the prospect of elevated interest rates for a longer time horizon linger on investors’ minds, even as…
[ad_1] CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving…
[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin…
[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring…
[ad_1] Here are the biggest calls on Wall Street on Friday: TD Cowen downgrades Paychex to market perform from outperform…
[ad_1] Here are the biggest calls on Wall Street on Tuesday: TD Cowen names First Solar a top pick TD…
[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024…
[ad_1] Here are Tuesday biggest calls on Wall Street: Wells Fargo initiates Freshpet as overweight Wells said the online pet…
[ad_1] The stock market is enjoying its best week of 2023, but some names may have gotten ahead of themselves.…